<?xml version="1.0" encoding="UTF-8"?>
<ClinicalDocument xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <realmCode code="US"/>
  <typeId root="2.16.840.1.113883.1.3" extension="POCD_HD000040"/>
  <templateId root="2.16.840.1.113883.10.20.22.1.1" extension="2015-08-01"/>
  <templateId root="2.16.840.1.113883.10.20.22.1.9" extension="2015-08-01"/>
  <id root="3dd99364-7760-40b6-a639-23258eef222d"/>
  <code code="11506-3" codeSystem="2.16.840.1.113883.6.1" codeSystemName="LOINC" displayName="Progress note"/>
  <title>SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 2 — Focused Visit (Follow-up) — Barbara Jordan — True-date frame: synthetic events are moved into the patient&apos;s historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.</title>
  <effectiveTime value="19800316120000-0500"/>
  <confidentialityCode code="N" codeSystem="2.16.840.1.113883.5.25"/>
  <languageCode code="en-US"/>
  <setId root="3b1f8697-fb68-4b14-a94d-99ddb65e99cb"/>
  <versionNumber value="1"/>
  <recordTarget>
    <patientRole>
      <id root="bc52c179-8819-48f2-9084-cd39280ee4f9" extension="HR-ML030-SYN-TD"/>
      <id root="2.16.840.1.113883.4.1" extension="000-30-6852"/>
      <addr nullFlavor="UNK"/>
      <telecom nullFlavor="UNK"/>
      <patient>
        <name use="L"><given>Barbara</given><family>Jordan</family></name>
        <administrativeGenderCode code="F" codeSystem="2.16.840.1.113883.5.1" displayName="Female"/>
        <birthTime value="19360221"/>
        <raceCode nullFlavor="ASKU"/>
        <ethnicGroupCode nullFlavor="ASKU"/>
        <languageCommunication><languageCode code="en"/><preferenceInd value="true"/></languageCommunication>
      </patient>
      <providerOrganization>
        <id root="6a7f851b-842b-45d7-9552-3e8582647414"/>
        <name>St. Posthumous Health Center</name>
      <telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr>
      </providerOrganization>
    </patientRole>
  </recordTarget>
  <author>
    <time value="19800316120000-0500"/>
    <assignedAuthor><id root="0d72a8ac-e944-482c-916b-3969ce8fa4a4"/><addr nullFlavor="UNK"/><telecom nullFlavor="UNK"/><assignedPerson><name><given>Evangeline</given><family>Moss</family><suffix>MD</suffix></name></assignedPerson><representedOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></representedOrganization></assignedAuthor>
  </author>
  <custodian>
    <assignedCustodian><representedCustodianOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></representedCustodianOrganization></assignedCustodian>
  </custodian>
  <legalAuthenticator>
    <time value="19800316120000-0500"/>
    <signatureCode code="S"/>
    <assignedEntity><id root="0d72a8ac-e944-482c-916b-3969ce8fa4a4"/><addr nullFlavor="UNK"/><telecom nullFlavor="UNK"/><assignedPerson><name><given>Evangeline</given><family>Moss</family><suffix>MD</suffix></name></assignedPerson><representedOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></representedOrganization></assignedEntity>
  </legalAuthenticator>
  <documentationOf>
    <serviceEvent classCode="PCPR"><templateId root="2.16.840.1.113883.10.20.21.3.1"/><effectiveTime><low value="19800316"/><high value="19800316"/></effectiveTime><performer typeCode="PRF"><assignedEntity><id root="0d72a8ac-e944-482c-916b-3969ce8fa4a4"/><addr nullFlavor="UNK"/><telecom nullFlavor="UNK"/><assignedPerson><name><given>Evangeline</given><family>Moss</family><suffix>MD</suffix></name></assignedPerson><representedOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></representedOrganization></assignedEntity></performer></serviceEvent>
  </documentationOf>
  <componentOf>
    <encompassingEncounter>
      <id root="3a8b7ce2-bad2-4b25-ad40-90dd38920d27"/>
      <code code="390906007" codeSystem="2.16.840.1.113883.6.96" displayName="Follow-up encounter"><originalText>Two-week review with MRI of the brain and spine and the neurology (multiple sclerosis) consultation; vaccines before therapy</originalText></code>
      <effectiveTime><low value="19800316"/><high value="19800316"/></effectiveTime>
      <encounterParticipant typeCode="ATND"><assignedEntity><id root="0d72a8ac-e944-482c-916b-3969ce8fa4a4"/><addr nullFlavor="UNK"/><telecom nullFlavor="UNK"/><assignedPerson><name><given>Evangeline</given><family>Moss</family><suffix>MD</suffix></name></assignedPerson><representedOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></representedOrganization></assignedEntity></encounterParticipant>
      <location><healthCareFacility><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><serviceProviderOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></serviceProviderOrganization></healthCareFacility></location>
    </encompassingEncounter>
  </componentOf>
  <component>
    <structuredBody>

<component>
  <section>
    <templateId root="1.3.6.1.4.1.19376.1.5.3.1.1.13.2.1"/>
    <code code="10154-3" codeSystem="2.16.840.1.113883.6.1" displayName="Chief complaint Narrative - Reported"/>
    <title>Chief Complaint</title>
    <text><paragraph>Two-week review with MRI of the brain and spine, seen the same day by multiple sclerosis neurology. [S]</paragraph></text>

  </section>
</component>

<component>
  <section>
    <templateId root="1.3.6.1.4.1.19376.1.5.3.1.3.4"/>
    <code code="10164-2" codeSystem="2.16.840.1.113883.6.1" displayName="History of Present illness Narrative"/>
    <title>History of Present Illness</title>
    <text><paragraph>Ms. Jordan returns two weeks after her first visit, after MRI of the brain and spine this morning, and is seen by Dr. Watanabe of multiple sclerosis neurology on the same day. Her walking is unchanged: she uses her cane on campus and rests after about 100 meters. She has had no new symptoms and no symptom that came on over days. Her legs are stiff in the mornings. She still gets up twice a night to pass urine and sometimes has to hurry. She has started vitamin D3. The records of her original evaluation have not arrived. She asked about treatments that might slow the disease and how often she would need to be away from work for them. [S]</paragraph><table><thead><tr><th>Element</th><th>Detail</th></tr></thead><tbody><tr><td>Walking</td><td>Cane on campus; rests after about 100 meters; unchanged</td></tr><tr><td>New symptoms</td><td>None</td></tr><tr><td>Bladder</td><td>Urgency; up twice a night</td></tr><tr><td>Imaging</td><td>MRI of the brain and cervical and thoracic spine with gadolinium this morning</td></tr></tbody></table></text>

  </section>
</component>

<component>
  <section>
    <templateId root="1.3.6.1.4.1.19376.1.5.3.1.3.18"/>
    <code code="10187-3" codeSystem="2.16.840.1.113883.6.1" displayName="Review of systems Narrative - Reported"/>
    <title>Review of Systems</title>
    <text><table><thead><tr><th>System</th><th>Result</th><th>Finding</th></tr></thead><tbody><tr><td>Constitutional</td><td>Positive</td><td>Tires by mid-afternoon; no fever</td></tr><tr><td>Eyes</td><td>Negative</td><td>No blurred or double vision</td></tr><tr><td>Genitourinary</td><td>Positive</td><td>Urgency and nocturia twice; no burning</td></tr><tr><td>Musculoskeletal</td><td>Positive</td><td>Leg stiffness in the mornings</td></tr><tr><td>Neurological</td><td>Positive</td><td>Slowly worsening walking; no new numbness or weakness</td></tr><tr><td>Psychiatric</td><td>Negative</td><td>Mood steady</td></tr></tbody></table><paragraph>6 systems reviewed. [S]</paragraph></text>

  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.22.2.1" extension="2014-06-09"/><templateId root="2.16.840.1.113883.10.20.22.2.1.1" extension="2014-06-09"/>
    <code code="10160-0" codeSystem="2.16.840.1.113883.6.1" displayName="History of Medication use Narrative"/>
    <title>Medications</title>
    <text><table><thead><tr><th>Medication</th><th>Frequency</th><th>Route</th><th>Dates</th><th>Status</th><th>Evidence</th></tr></thead><tbody><tr ID="medication-1"><td>Cholecalciferol (vitamin D3) 1954 units (50 mcg) oral capsule, one capsule daily</td><td>One capsule daily</td><td>Oral route</td><td>1980-03-02</td><td>active</td><td>S</td></tr><tr ID="medication-2"><td>Baclofen 5 mg oral tablet, one tablet three times a day, to be increased to 10 mg three times a day once tolerated</td><td>One tablet three times a day</td><td>Oral route</td><td>1980-03-16 to 1980-04-20</td><td>completed</td><td>S</td></tr><tr ID="medication-4"><td>Mirabegron 25 mg extended-release oral tablet, one tablet daily</td><td>One tablet daily</td><td>Oral route</td><td>1980-03-16</td><td>active</td><td>S</td></tr></tbody></table></text>

  <entry typeCode="DRIV">
    <substanceAdministration classCode="SBADM" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.16" extension="2014-06-09"/>
      <id root="83f00db7-2038-4f02-b194-2dc7616d3a53"/>
      <text><reference value="#medication-1"/></text>
      <statusCode code="active"/>
      <effectiveTime xsi:type="IVL_TS"><low value="19800302"/></effectiveTime>
      <effectiveTime xsi:type="PIVL_TS" institutionSpecified="false" operator="A"><period value="1" unit="d"/></effectiveTime>
      <routeCode code="C38288" codeSystem="2.16.840.1.113883.3.26.1.1" codeSystemName="NCI Thesaurus" displayName="Oral route"/>
      <doseQuantity value="1"/>
      <consumable>
        <manufacturedProduct classCode="MANU">
          <templateId root="2.16.840.1.113883.10.20.22.4.23" extension="2014-06-09"/>
          <manufacturedMaterial><code code="804146" codeSystem="2.16.840.1.113883.6.88" displayName="cholecalciferol 0.05 MG Oral Capsule"/></manufacturedMaterial>
        </manufacturedProduct>
      </consumable>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="f801eeed-e38d-4ab1-bc46-d33690733833"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="E55.9" codeSystem="2.16.840.1.113883.6.90" displayName="Vitamin D deficiency, unspecified"/>
        </observation>
      </entryRelationship>
    </substanceAdministration>
  </entry>
  <entry typeCode="DRIV">
    <substanceAdministration classCode="SBADM" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.16" extension="2014-06-09"/>
      <id root="637abad2-413a-43df-8022-9416f5ba8867"/>
      <text><reference value="#medication-2"/></text>
      <statusCode code="completed"/>
      <effectiveTime xsi:type="IVL_TS"><low value="19800316"/><high value="19800420"/></effectiveTime>
      <effectiveTime xsi:type="PIVL_TS" institutionSpecified="false" operator="A"><period value="8" unit="h"/></effectiveTime>
      <routeCode code="C38288" codeSystem="2.16.840.1.113883.3.26.1.1" codeSystemName="NCI Thesaurus" displayName="Oral route"/>
      <doseQuantity value="1"/>
      <consumable>
        <manufacturedProduct classCode="MANU">
          <templateId root="2.16.840.1.113883.10.20.22.4.23" extension="2014-06-09"/>
          <manufacturedMaterial><code code="430902" codeSystem="2.16.840.1.113883.6.88" displayName="baclofen 5 MG Oral Tablet"/></manufacturedMaterial>
        </manufacturedProduct>
      </consumable>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="26a3c149-c553-4588-b9ca-5a4c3fb0d744"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="G35.B1" codeSystem="2.16.840.1.113883.6.90" displayName="Active primary progressive multiple sclerosis"/>
        </observation>
      </entryRelationship>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="0efbce76-18b0-46bb-8bd9-1416cc8af121"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="R26.89" codeSystem="2.16.840.1.113883.6.90" displayName="Other abnormalities of gait and mobility"/>
        </observation>
      </entryRelationship>
    </substanceAdministration>
  </entry>
  <entry typeCode="DRIV">
    <substanceAdministration classCode="SBADM" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.16" extension="2014-06-09"/>
      <id root="f1036083-b7f3-43e5-8b1b-82540b6efbd4"/>
      <text><reference value="#medication-4"/></text>
      <statusCode code="active"/>
      <effectiveTime xsi:type="IVL_TS"><low value="19800316"/></effectiveTime>
      <effectiveTime xsi:type="PIVL_TS" institutionSpecified="false" operator="A"><period value="1" unit="d"/></effectiveTime>
      <routeCode code="C38288" codeSystem="2.16.840.1.113883.3.26.1.1" codeSystemName="NCI Thesaurus" displayName="Oral route"/>
      <doseQuantity value="1"/>
      <consumable>
        <manufacturedProduct classCode="MANU">
          <templateId root="2.16.840.1.113883.10.20.22.4.23" extension="2014-06-09"/>
          <manufacturedMaterial><code code="1300791" codeSystem="2.16.840.1.113883.6.88" displayName="24 HR mirabegron 25 MG Extended Release Oral Tablet"/></manufacturedMaterial>
        </manufacturedProduct>
      </consumable>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="d20545a0-a2a1-44d4-8885-d142278f81b1"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="N31.9" codeSystem="2.16.840.1.113883.6.90" displayName="Neuromuscular dysfunction of bladder, unspecified"/>
        </observation>
      </entryRelationship>
    </substanceAdministration>
  </entry>
  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.22.2.6" extension="2015-08-01"/><templateId root="2.16.840.1.113883.10.20.22.2.6.1" extension="2015-08-01"/>
    <code code="48765-2" codeSystem="2.16.840.1.113883.6.1" displayName="Allergies and adverse reactions Document"/>
    <title>Allergies and Intolerances</title>
    <text><table><thead><tr><th>Allergy</th><th>Reaction</th><th>Status</th><th>Evidence</th></tr></thead><tbody><tr ID="allergy-1"><td>No known allergy</td><td></td><td>active</td><td>S</td></tr></tbody></table></text>

  <entry typeCode="DRIV">
    <act classCode="ACT" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.30" extension="2015-08-01"/>
      <id root="a81087e9-1170-4a32-82fb-d4a1b832c379"/>
      <code code="CONC" codeSystem="2.16.840.1.113883.5.6" displayName="Concern"/>
      <statusCode code="active"/>
      <effectiveTime><low value="19800302"/></effectiveTime>
      <entryRelationship typeCode="SUBJ">
        <observation classCode="OBS" moodCode="EVN" negationInd="true">
          <templateId root="2.16.840.1.113883.10.20.22.4.7" extension="2014-06-09"/>
          <id root="33eb2742-0124-4234-bc16-861ee9c1d8c1"/>
          <code code="ASSERTION" codeSystem="2.16.840.1.113883.5.4"/>
          <text><reference value="#allergy-1"/></text>
          <statusCode code="completed"/>
          <effectiveTime><low nullFlavor="UNK"/></effectiveTime>
          <value xsi:type="CD" code="419199007" codeSystem="2.16.840.1.113883.6.96" displayName="Allergy to substance"/>
          <participant typeCode="CSM"><participantRole classCode="MANU"><playingEntity classCode="MMAT"><code nullFlavor="NA"/></playingEntity></participantRole></participant>
        </observation>
      </entryRelationship>
    </act>
  </entry>
  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.22.2.4" extension="2015-08-01"/><templateId root="2.16.840.1.113883.10.20.22.2.4.1" extension="2015-08-01"/>
    <code code="8716-3" codeSystem="2.16.840.1.113883.6.1" displayName="Vital signs"/>
    <title>Vital Signs</title>
    <text><table><thead><tr><th>Date</th><th>Measure</th><th>Value</th><th>Unit</th><th>Provenance</th></tr></thead><tbody>
  <tr ID="vital-2-1"><td>1980-03-16</td><td>Body height</td><td>173</td><td>cm</td><td>S</td></tr>
  <tr ID="vital-2-2"><td>1980-03-16</td><td>Body weight</td><td>84.2</td><td>kg</td><td>S</td></tr>
  <tr ID="vital-2-3"><td>1980-03-16</td><td>Body mass index (BMI) [Ratio]</td><td>28.1</td><td>kg/m2</td><td>S</td></tr>
  <tr ID="vital-2-4"><td>1980-03-16</td><td>Systolic blood pressure</td><td>122</td><td>mm[Hg]</td><td>S</td></tr>
  <tr ID="vital-2-5"><td>1980-03-16</td><td>Diastolic blood pressure</td><td>76</td><td>mm[Hg]</td><td>S</td></tr>
  <tr ID="vital-2-6"><td>1980-03-16</td><td>Heart rate</td><td>74</td><td>/min</td><td>S</td></tr>
  <tr ID="vital-2-7"><td>1980-03-16</td><td>Respiratory rate</td><td>16</td><td>/min</td><td>S</td></tr>
  <tr ID="vital-2-8"><td>1980-03-16</td><td>Body temperature</td><td>36.6</td><td>Cel</td><td>S</td></tr>
  <tr ID="vital-2-9"><td>1980-03-16</td><td>Oxygen saturation in Arterial blood by Pulse oximetry</td><td>98</td><td>%</td><td>S</td></tr></tbody></table></text>

  <entry typeCode="DRIV">
    <organizer classCode="CLUSTER" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.26" extension="2015-08-01"/>
      <id root="b8dcb0f0-1372-4eed-babe-d243dcbdef07"/>
      <code code="74728-7" codeSystem="2.16.840.1.113883.6.1" displayName="Vital signs, weight, height, head circumference, oximetry, BMI, and BSA panel - HL7.FHIR.R4"/>
      <statusCode code="completed"/><effectiveTime value="19800316"/>
      <component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="71838d73-5612-4fa8-9117-3d71f5b22df2"/><code code="8302-2" codeSystem="2.16.840.1.113883.6.1" displayName="Body height"/><text><reference value="#vital-2-1"/></text><statusCode code="completed"/><effectiveTime value="19800316"/><value xsi:type="PQ" value="173" unit="cm"/></observation></component><component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="bcd6af12-cf4f-4840-8bc5-8a8cad26b868"/><code code="29463-7" codeSystem="2.16.840.1.113883.6.1" displayName="Body weight"/><text><reference value="#vital-2-2"/></text><statusCode code="completed"/><effectiveTime value="19800316"/><value xsi:type="PQ" value="84.2" unit="kg"/></observation></component><component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="84ab9be7-9474-430d-a414-e27f345fdb6b"/><code code="39156-5" codeSystem="2.16.840.1.113883.6.1" displayName="Body mass index (BMI) [Ratio]"/><text><reference value="#vital-2-3"/></text><statusCode code="completed"/><effectiveTime value="19800316"/><value xsi:type="PQ" value="28.1" unit="kg/m2"/></observation></component><component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="17419940-9c75-4e37-bd1e-aac4396b0e1e"/><code code="8480-6" codeSystem="2.16.840.1.113883.6.1" displayName="Systolic blood pressure"/><text><reference value="#vital-2-4"/></text><statusCode code="completed"/><effectiveTime value="19800316"/><value xsi:type="PQ" value="122" unit="mm[Hg]"/></observation></component><component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="9efc8f37-6698-434e-9d37-49907ea62a00"/><code code="8462-4" codeSystem="2.16.840.1.113883.6.1" displayName="Diastolic blood pressure"/><text><reference value="#vital-2-5"/></text><statusCode code="completed"/><effectiveTime value="19800316"/><value xsi:type="PQ" value="76" unit="mm[Hg]"/></observation></component><component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="c225e405-e833-41e7-8d88-e08968e25f1b"/><code code="8867-4" codeSystem="2.16.840.1.113883.6.1" displayName="Heart rate"/><text><reference value="#vital-2-6"/></text><statusCode code="completed"/><effectiveTime value="19800316"/><value xsi:type="PQ" value="74" unit="/min"/></observation></component><component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="60e28d6c-4bf9-4aeb-b4e7-9881f4dfa9e9"/><code code="9279-1" codeSystem="2.16.840.1.113883.6.1" displayName="Respiratory rate"/><text><reference value="#vital-2-7"/></text><statusCode code="completed"/><effectiveTime value="19800316"/><value xsi:type="PQ" value="16" unit="/min"/></observation></component><component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="c8286130-4080-47d4-8f9e-80ba0fa36945"/><code code="8310-5" codeSystem="2.16.840.1.113883.6.1" displayName="Body temperature"/><text><reference value="#vital-2-8"/></text><statusCode code="completed"/><effectiveTime value="19800316"/><value xsi:type="PQ" value="36.6" unit="Cel"/></observation></component><component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="fc62f818-beca-4d3f-b6e3-91a5a9401fb5"/><code code="59408-5" codeSystem="2.16.840.1.113883.6.1" displayName="Oxygen saturation in Arterial blood by Pulse oximetry"/><text><reference value="#vital-2-9"/></text><statusCode code="completed"/><effectiveTime value="19800316"/><value xsi:type="PQ" value="98" unit="%"/></observation></component>
    </organizer>
  </entry>
  </section>
</component>

<component>
  <section nullFlavor="NI">
    <templateId root="2.16.840.1.113883.10.20.22.2.3" extension="2015-08-01"/><templateId root="2.16.840.1.113883.10.20.22.2.3.1" extension="2015-08-01"/>
    <code code="30954-2" codeSystem="2.16.840.1.113883.6.1"/>
    <title>Results</title>
    <text><paragraph>No results recorded at this visit.</paragraph></text>
  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.2.10" extension="2015-08-01"/>
    <code code="29545-1" codeSystem="2.16.840.1.113883.6.1" displayName="Physical findings note"/>
    <title>Physical Exam</title>
    <text><paragraph>Vital signs recorded on 1980-03-16; see the Vital Signs section. [S]</paragraph><table><thead><tr><th>System</th><th>Finding</th></tr></thead><tbody><tr><td>General</td><td>Well; blood pressure 122/76, pulse 74</td></tr><tr><td>Neurological</td><td>Spastic paraparetic gait with a cane in the right hand; hip flexor strength 4 out of 5 on both sides; modified Ashworth 2 in both legs; brisk leg reflexes with extensor plantar responses; reduced vibration sense at the toes; EDSS 6.0; timed 25-foot walk 11.0 seconds</td></tr><tr><td>Eyes</td><td>Visual acuity 20/20 in each eye; no relative afferent pupillary defect</td></tr></tbody></table></text>

  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.22.2.5" extension="2015-08-01"/><templateId root="2.16.840.1.113883.10.20.22.2.5.1" extension="2015-08-01"/>
    <code code="11450-4" codeSystem="2.16.840.1.113883.6.1" displayName="Problem List"/>
    <title>Problems</title>
    <text><table><thead><tr><th>Problem</th><th>Clinical status</th><th>Verification</th><th>Code</th><th>Provenance</th></tr></thead><tbody>
  <tr ID="problem-1">
    <td>Multiple sclerosis diagnosed elsewhere, by her account, with records of the original evaluation not available: slowly worsening walking over the past few years, leg stiffness, fatigue, urinary urgency and heat sensitivity; uses a cane; course to be classified after MRI of the brain and spine</td><td>resolved</td><td>confirmed</td>
    <td>G35.D</td><td>S — Synthetic presenting picture at intake, superseded by the classified diagnosis at the consultation; the cane and a diagnosis around the time she left Congress are from public accounts.</td>
  </tr>
  <tr ID="problem-2">
    <td>Active primary progressive multiple sclerosis: gradual worsening of walking over more than a year without relapses, with brain lesions in periventricular, juxtacortical and infratentorial regions, three spinal cord lesions, and one gadolinium-enhancing lesion; fulfils the 1971 McDonald criteria for primary progressive disease; EDSS 6.0; synthetic modern detail linked to her publicly reported multiple sclerosis</td><td>active</td><td>confirmed</td>
    <td>G35.B1</td><td>S — Synthetic course, MRI findings and disability score; the disease itself and her use of a cane are from public accounts.</td>
  </tr>
  <tr ID="problem-3">
    <td>Spastic gait from multiple sclerosis, walking with a cane, with two near-falls and no falls in the past year; at risk of falls</td><td>active</td><td>confirmed</td>
    <td>R26.89</td><td>S — Synthetic modern coding anchored to her documented cane.</td>
  </tr>
  <tr ID="problem-4">
    <td>Neurogenic bladder from multiple sclerosis: urgency and getting up twice at night, with a low post-void residual</td><td>active</td><td>confirmed</td>
    <td>N31.9</td><td>S — Synthetic; common in multiple sclerosis. No public source describes her bladder.</td>
  </tr>
  <tr ID="problem-5">
    <td>Vitamin D deficiency</td><td>active</td><td>confirmed</td>
    <td>E55.9</td><td>S — Synthetic laboratory finding at intake.</td>
  </tr></tbody></table></text>

  <entry typeCode="DRIV">
    <act classCode="ACT" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.3" extension="2015-08-01"/>
      <id root="266d641c-94dc-4b84-b245-0ccf46cced14"/>
      <code code="CONC" codeSystem="2.16.840.1.113883.5.6" displayName="Concern"/>
      <statusCode code="completed"/>
      <effectiveTime><low value="19800302"/><high value="19800316"/></effectiveTime>
      <entryRelationship typeCode="SUBJ">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.4" extension="2015-08-01"/>
          <id root="3c2dcc92-8956-4622-91e6-f07a29af86fd"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <text><reference value="#problem-1"/></text>
          <statusCode code="completed"/>
          <effectiveTime><low value="19800302"/><high value="19800316"/></effectiveTime>
          <value xsi:type="CD" code="G35.D" codeSystem="2.16.840.1.113883.6.90" displayName="Multiple sclerosis, unspecified"/>
        </observation>
      </entryRelationship>
    </act>
  </entry>
  <entry typeCode="DRIV">
    <act classCode="ACT" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.3" extension="2015-08-01"/>
      <id root="85cb168d-1a45-4b22-8b02-e68406b909be"/>
      <code code="CONC" codeSystem="2.16.840.1.113883.5.6" displayName="Concern"/>
      <statusCode code="active"/>
      <effectiveTime><low value="19800316"/></effectiveTime>
      <entryRelationship typeCode="SUBJ">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.4" extension="2015-08-01"/>
          <id root="627e4ae9-c03e-45ad-9e14-ecc1e1c8e68c"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <text><reference value="#problem-2"/></text>
          <statusCode code="completed"/>
          <effectiveTime><low value="19800316"/></effectiveTime>
          <value xsi:type="CD" code="G35.B1" codeSystem="2.16.840.1.113883.6.90" displayName="Active primary progressive multiple sclerosis"/>
        </observation>
      </entryRelationship>
    </act>
  </entry>
  <entry typeCode="DRIV">
    <act classCode="ACT" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.3" extension="2015-08-01"/>
      <id root="c21264ef-da17-4df4-9064-a573a678ec0e"/>
      <code code="CONC" codeSystem="2.16.840.1.113883.5.6" displayName="Concern"/>
      <statusCode code="active"/>
      <effectiveTime><low value="19800302"/></effectiveTime>
      <entryRelationship typeCode="SUBJ">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.4" extension="2015-08-01"/>
          <id root="994979f4-bd17-476e-a1b4-1867924fbea1"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <text><reference value="#problem-3"/></text>
          <statusCode code="completed"/>
          <effectiveTime><low value="19800302"/></effectiveTime>
          <value xsi:type="CD" code="R26.89" codeSystem="2.16.840.1.113883.6.90" displayName="Other abnormalities of gait and mobility"/>
        </observation>
      </entryRelationship>
    </act>
  </entry>
  <entry typeCode="DRIV">
    <act classCode="ACT" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.3" extension="2015-08-01"/>
      <id root="c36f2bd0-53b6-43fc-ad57-186647034d7b"/>
      <code code="CONC" codeSystem="2.16.840.1.113883.5.6" displayName="Concern"/>
      <statusCode code="active"/>
      <effectiveTime><low value="19800302"/></effectiveTime>
      <entryRelationship typeCode="SUBJ">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.4" extension="2015-08-01"/>
          <id root="c0674633-cc10-4211-8501-7caa291471cd"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <text><reference value="#problem-4"/></text>
          <statusCode code="completed"/>
          <effectiveTime><low value="19800302"/></effectiveTime>
          <value xsi:type="CD" code="N31.9" codeSystem="2.16.840.1.113883.6.90" displayName="Neuromuscular dysfunction of bladder, unspecified"/>
        </observation>
      </entryRelationship>
    </act>
  </entry>
  <entry typeCode="DRIV">
    <act classCode="ACT" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.3" extension="2015-08-01"/>
      <id root="a48ea24b-80f6-4e17-aff3-7ce4353bd3e7"/>
      <code code="CONC" codeSystem="2.16.840.1.113883.5.6" displayName="Concern"/>
      <statusCode code="active"/>
      <effectiveTime><low value="19800302"/></effectiveTime>
      <entryRelationship typeCode="SUBJ">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.4" extension="2015-08-01"/>
          <id root="c1c43d59-6d2d-4be6-8219-292d06a104d9"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <text><reference value="#problem-5"/></text>
          <statusCode code="completed"/>
          <effectiveTime><low value="19800302"/></effectiveTime>
          <value xsi:type="CD" code="E55.9" codeSystem="2.16.840.1.113883.6.90" displayName="Vitamin D deficiency, unspecified"/>
        </observation>
      </entryRelationship>
    </act>
  </entry>
  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.22.2.9" extension="2014-06-09"/>
    <code code="51847-2" codeSystem="2.16.840.1.113883.6.1" displayName="Evaluation + Plan note"/>
    <title>Assessment and Plan</title>
    <text><list listType="ordered"><item><content styleCode="Bold">Active primary progressive multiple sclerosis (G35.B1)</content>. MRI brain: fourteen T2 lesions, periventricular, juxtacortical and infratentorial (pons and left middle cerebellar peduncle), one enhancing right periventricular lesion. MRI spine: three cord lesions at C3, C5 and T6, each less than two segments long, with no compression. With more than a year of gradually worsening walking and no relapses, these meet the 1971 McDonald criteria for primary progressive multiple sclerosis (brain lesions in characteristic regions and two or more cord lesions), and the enhancing lesion makes it active. B12, TSH and HIV results exclude the main mimics. Dr. Watanabe advises ocrelizumab. Screening before therapy: hepatitis B surface antigen, core antibody and surface antibody all negative (not infected, not immune); immunoglobulins, liver tests and blood count normal; varicella IgG and measles, mumps and rubella IgG positive; tuberculosis blood test, HIV and hepatitis C negative; JC virus antibody index 0.14, negative. [S]<list><item>Vaccines today: PCV20, recombinant zoster dose 1, Tdap and hepatitis B dose 1; second zoster and hepatitis B doses in about five weeks.</item><item>First ocrelizumab half-dose at least two weeks after the last vaccine.</item><item>Reproductive plans discussed privately with Dr. Watanabe and recorded in the confidential part of the chart.</item></list></item><item><content styleCode="Bold">Spastic gait and fall risk (R26.89)</content>. Spasticity limits her walking and stiffens her mornings; no falls. [S]<list><item>Start baclofen 5 mg three times a day, increasing to 10 mg three times a day once tolerated.</item><item>Physical therapy evaluation requested at intake; awaiting a first appointment.</item></list></item><item><content styleCode="Bold">Neurogenic bladder (N31.9)</content>. Urgency with a low post-void residual of 40 mL at intake, so a bladder-relaxing medicine is safe. [S]<list><item>Start mirabegron 25 mg daily rather than an anticholinergic, to avoid effects on concentration; blood pressure at each visit.</item><item>Continue timed voiding and fluids earlier in the day.</item></list></item></list><paragraph>Protocol monitoring: items the monitoring protocol calls for at this visit. [S]</paragraph><table><thead><tr><th>Domain</th><th>Measure</th><th>Interval</th><th>Status</th><th>Detail</th></tr></thead><tbody><tr><td>Examination</td><td>New or worsening symptoms (relapse, pseudo-relapse with heat or infection)</td><td>Every visit</td><td>Completed today</td><td>No new symptoms; relapse and pseudo-relapse plan explained with a written card</td></tr><tr><td>Examination</td><td>Disability: EDSS and timed 25-foot walk</td><td>Every visit, and at least every 6 months</td><td>Completed today</td><td>EDSS 6.0; timed 25-foot walk 11.0 seconds</td></tr><tr><td>Imaging</td><td>Brain MRI</td><td>At diagnosis with gadolinium; re-baseline 3 to 6 months after starting therapy; then yearly without routine gadolinium</td><td>Completed today</td><td>Diagnostic MRI with gadolinium: fourteen T2 lesions in characteristic regions; one enhancing lesion</td></tr><tr><td>Imaging</td><td>Spinal cord MRI</td><td>At diagnosis; later only for new spinal symptoms or diagnostic doubt</td><td>Completed today</td><td>Three cord lesions; no compression</td></tr><tr><td>Laboratory</td><td>Hepatitis B surface antigen, core antibody and surface antibody</td><td>Before the first dose</td><td>Up to date</td><td>All negative at intake: not infected, not immune; vaccination started today</td></tr><tr><td>Laboratory</td><td>Quantitative immunoglobulins</td><td>Before the first dose, then before each dose</td><td>Up to date</td><td>IgG 1080, IgM 110, IgA 210 mg/dL at intake</td></tr><tr><td>Laboratory</td><td>Blood count with absolute lymphocytes</td><td>Before the first dose, then before each dose</td><td>Up to date</td><td>White cells 6.4, lymphocytes 1.9 at intake</td></tr><tr><td>Laboratory</td><td>Liver tests</td><td>Before the first dose, then with symptoms and before each dose</td><td>Up to date</td><td>Normal at intake</td></tr><tr><td>Laboratory</td><td>Varicella and measles immunity, tuberculosis blood test, HIV, hepatitis C, JC virus antibody</td><td>Before the first dose</td><td>Up to date</td><td>Varicella and measles immune; tuberculosis blood test, HIV and hepatitis C negative; JC virus antibody index 0.14</td></tr><tr><td>Medication safety</td><td>Vaccines before therapy (PCV20, recombinant zoster x2, Tdap, hepatitis B x2)</td><td>Inactivated at least 2 weeks and live at least 4 weeks before the first dose</td><td>Completed today</td><td>PCV20, zoster dose 1, Tdap and hepatitis B dose 1 today; no live vaccine needed</td></tr><tr><td>Examination</td><td>Spasticity (modified Ashworth) and baclofen tolerance</td><td>Every visit</td><td>Completed today</td><td>Modified Ashworth 2 in both legs; baclofen started</td></tr><tr><td>Examination</td><td>Bladder: urgency, nocturia, urinary infection, and blood pressure on mirabegron</td><td>Every visit</td><td>Completed today</td><td>Urgency and nocturia twice; post-void residual 40 mL at intake; mirabegron started; blood pressure 122/76</td></tr><tr><td>Referral</td><td>Falls, walking aids and physical therapy</td><td>Every visit</td><td>Ordered</td><td>No falls; physical therapy evaluation requested at intake, first appointment awaited</td></tr><tr><td>Self-management</td><td>Fatigue and heat sensitivity</td><td>Every visit</td><td>Completed today</td><td>Tires by mid-afternoon; pacing and cooling advice given</td></tr><tr><td>Laboratory</td><td>25-hydroxyvitamin D</td><td>At baseline, 8 to 12 weeks after repletion, then yearly</td><td>Up to date</td><td>17 ng/mL at intake; vitamin D3 started at intake</td></tr><tr><td>Survey</td><td>Depression screen (PHQ-9)</td><td>At intake, then every 6 months and with any change</td><td>Up to date</td><td>PHQ-9 6 at intake, mostly fatigue and sleep items</td></tr><tr><td>Self-management</td><td>Workplace accommodation</td><td>At intake and with any change</td><td>Completed today</td><td>Letter describing her functional needs, without the diagnosis, given to her to send as she chooses</td></tr><tr><td>Referral</td><td>Multiple sclerosis neurology review</td><td>At diagnosis, then every 6 months on therapy</td><td>Completed today</td><td>Seen by Dr. Watanabe today</td></tr></tbody></table><paragraph>Goal progress:</paragraph><list><item>Diagnosis confirmed and classified, vaccines completed at least two weeks before therapy, and a disease-modifying therapy started within ten weeks. In progress; target 1980-06-29 [S]</item><item>No falls through eight months. In progress; target 1980-10-26 [S]</item><item>25-hydroxyvitamin D at least 30 ng/mL within four months. In progress; target 1980-06-29 [S]</item><item>Up no more than once a night to pass urine within three months. In progress; target 1980-06-29 [S]</item><item>Keep her full teaching and speaking schedule with the accommodations she chooses. In progress; target 1980-10-26 [S]</item><item>No new or enlarging T2 lesions on the re-baseline MRI. In progress; target 1980-10-26 [S]</item></list><paragraph>Immunizations given today: Pneumococcal conjugate vaccine PCV20; Recombinant zoster vaccine, dose 1 of 2; Tetanus, diphtheria, and acellular pertussis vaccine (Tdap); Hepatitis B vaccine (HepB-CpG), dose 1 of 2 [S]</paragraph><paragraph>Guideline basis: Practice guideline recommendations summary: Disease-modifying therapies for adults with multiple sclerosis (Rae-Grant A, et al.; PMID 29686116) (2018); Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria (Thompson AJ, et al.; PMID 29275977) (2017); 2021 MAGNIMS-CMSC-NAIMS consensus recommendations on the use of MRI in patients with multiple sclerosis (Wattjes MP, et al.; PMID 34139157) (2021); Practice guideline update summary: Vaccine-preventable infections and immunization in multiple sclerosis (Farez MF, et al.; PMID 31462584) (2019); OCREVUS (ocrelizumab) injection, prescribing information (2026); Multiple sclerosis in adults: management (NG220) (2022); Accommodation and Compliance: Multiple Sclerosis (2026); Introduction to the Americans with Disabilities Act (2026); Adult Immunization Schedule by Age (2026)</paragraph><paragraph>Follow-up: Review in five weeks for the second vaccine doses and baclofen titration; first ocrelizumab infusion to be booked at least two weeks after that visit. Same-day call for new or worsening symptoms lasting more than 24 hours. Next scheduled visit 1980-04-20: five-week review: second vaccine doses, baclofen titration, physical therapy and readiness for the first infusion. [S]</paragraph></text>

  </section>
</component>
    </structuredBody>
  </component>
</ClinicalDocument>
